<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>约翰·霍普金斯大学的研究人员发现性别确认手术后的遗憾最小</title><description>在 2023 年 12 月 27 日发表在《美国医学会杂志外科杂志》上的一篇观点文章中，三名约翰·霍普金斯大学研究人员敦促医学界驳回一种广泛持有但缺乏科学依据的信念，即许多跨性别者和性别多样化 (TGD) 的人会接受性别肯定手术（GAS），后来后悔他们决定接受此类手术。</description><link/> https://www.news-medical.net/news/20231228/Johns-Hopkins-researchers-find-minimal-regret-after-gender-affirming-surgery.aspx<comments> https://www.news-medical.net/news/20231228/Johns-Hopkins-researchers-find-minimal-regret-after-gender-affirming-surgery.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=e9f6ab16-6ebd-4bb5-a0d9-49260b3bbf98</guid><pubDate> Thu, 28 Dec 2023 22:17:50 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/shutterstock_1016603317_913529de2164475183968b0534c69347-620x480.jpg" width="620"><media:description><![CDATA[Johns Hopkins researchers find minimal regret after gender affirming surgery]]></media:description></media:content></item><item><title> “视觉系统”蛋白质似乎是稳定身体昼夜节律的关键</title><description>约翰·霍普金斯大学医学院和美国国立卫生研究院的科学家们在小鼠视觉系统中发现了一种蛋白质，它似乎是通过缓冲大脑对光的反应来稳定人体昼夜节律的关键。</description><link/> https://www.news-medical.net/news/20231228/Visual-system- Protein-appears-to-be-key-for-stabilizing-the-bodys-circadian-rhythms.aspx<comments> https://www.news-medical.net/news/20231228/Visual-system- Protein-appears-to-be-key-for-stabilizing-the-bodys-circadian-rhythms.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=adc8067a-f81e-4833-a24c-31ca4b39a9c1</guid><pubDate> Thu, 28 Dec 2023 21:56:49 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Protein-620x480.jpg" width="620"><media:description><![CDATA['Visual system' protein appears to be key for stabilizing the body's circadian rhythms]]></media:description></media:content></item><item><title> NCI 授予 1500 万美元拨款，用于研究一种治疗难治性癌症的放射疗法</title><description>由 George Sgouros 博士领导的约翰霍普金斯大学医学院的放射性药物治疗和剂量测定实验室已获得美国国立卫生研究院国家癌症研究所的 1500 万美元拨款，该拨款将在未来五年内发放。</description><link/> https://www.news-medical.net/news/20231228/2415-million-NCI-grant-awarded-to-investigate-a-type-of-radiation-therapy-for-hard-to-treat-cancers。 ASPX<comments> https://www.news-medical.net/news/20231228/2415-million-NCI-grant-awarded-to-investigate-a-type-of-radiation-therapy-for-hard-to-treat-cancers。 aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=089c481c-b4df-42be-b6c6-5d2ee0342acf</guid><pubDate> Thu, 28 Dec 2023 21:44:15 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Radiation_Therapy-620x480.jpg" width="620"><media:description><![CDATA[$15 million NCI grant awarded to investigate a type of radiation therapy for hard-to-treat cancers]]></media:description></media:content></item><item><title> GFH009 破坏血液恶性肿瘤中的生长信号并引发细胞凋亡</title><description>2023年12月20日，Oncotarget第14卷发表了一篇新的研究论文，题为“GFH009的抗肿瘤作用的药效学和机制基础，一种有效且高度选择性的CDK9抑制剂，用于治疗血液恶性肿瘤”。</description><link/> https://www.news-medical.net/news/20231228/GFH009-disrupts-growth-signals-and-triggers-apoptosis-in-hematologic-malignancies.aspx<comments> https://www.news-medical.net/news/20231228/GFH009-disrupts-growth-signals-and-triggers-apoptosis-in-hematologic-malignancies.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=392e681d-435c-4c0c-b2b0-fc3d8de15cc2</guid><pubDate> Thu, 28 Dec 2023 21:28:43 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/Cell_lysis._Destruction_of_a_cell_isolated_on_black_background._Can_be_used_to_i_-_Kateryna_Kon_M1_91d8442b439640429a2e3bdd7153aca5-620x480.jpg" width="620"><media:description><![CDATA[GFH009 disrupts growth signals and triggers apoptosis in hematologic malignancies]]></media:description></media:content></item><item><title>当归提取物成为血管疾病的潜在治疗方法</title><description>一篇新的研究论文发表在《Aging》杂志（MEDLINE/PubMed 列为“Aging (Albany NY)”和 Web of Science 列为“Aging-US”）第 15 卷第 23 期，题为“Angelica gigas extract Prevents acetate of eNOS via IRE1α磺化/RIDD-SIRT1介导的血管功能障碍的翻译后修饰。”</description><link/> https://www.news-medical.net/news/20231228/Angelica-gigas-extract-emerges-as-a-pottial-treatment-for-angio-disease.aspx<comments> https://www.news-medical.net/news/20231228/Angelica-gigas-extract-emerges-as-a-pottial-treatment-for-angio-disease.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=96234933-b166-4e78-8a91-1094380b9ff7</guid><pubDate> Thu, 28 Dec 2023 21:07:11 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Nitric_Oxide-620x480.jpg" width="620"><media:description><![CDATA[Angelica gigas extract emerges as a potential treatment for vascular disease]]></media:description></media:content></item><item><title>更好地诊断和治疗缺血性胆囊炎的新见解</title><description>缺血性胆囊炎是一种胆囊炎症，在没有胆结石或其他形式的外部压迫的情况下发生。</description><link/> https://www.news-medical.net/news/20231228/New-insights-on-better-diagnosis-and-treatment-of-ischemic-cholecystitis.aspx<comments> https://www.news-medical.net/news/20231228/New-insights-on-better-diagnosis-and-treatment-of-ischemic-cholecystitis.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=5a6b159a-2be0-40c4-8287-55d187b1590b</guid><pubDate> Thu, 28 Dec 2023 20:59:14 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Gastroenterology-620x480.jpg" width="620"><media:description><![CDATA[New insights on better diagnosis and treatment of ischemic cholecystitis]]></media:description></media:content></item><item><title>人工智能的进步可能会彻底改变肝细胞癌的诊断</title><description>肝细胞癌（HCC）是最常见的肝癌类型。这是一个主要的全球健康问题，发病率不断上升，特别是在北非和东亚。</description><link/> https://www.news-medical.net/news/20231228/AI-advances-could-revolutionize-hepatocellular-carcinoma-diagnosis.aspx<comments> https://www.news-medical.net/news/20231228/AI-advances-could-revolutionize-hepatocellular-carcinoma-diagnosis.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0a2e8f97-3fd9-4a5a-bbdc-d4b8388cf87b</guid><pubDate> Thu, 28 Dec 2023 20:49:37 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/futuristic_techno_design_on_background_of_supercomputer_data_center_-_Image_-_Timofeev_Vladimir_M1_402c068791b640469e416c4f55d84afe-620x480.jpg" width="620"><media:description><![CDATA[AI advances could revolutionize hepatocellular carcinoma diagnosis]]></media:description></media:content></item><item><title> Insilico Medicine 开发新的 AI 生成的 FGFR2/3 抑制剂，用于治疗组织不可知的实体瘤</title><description>Insilico Medicine（“Insilico”）是一家生成人工智能（AI）驱动的临床阶段药物发现公司，今天宣布提名 ISM8001，这是一种靶向 FGFR2/3 的新型分子，用于治疗与组织无关的实体瘤2023 年提名的 PCC 数量达到 6 个。</description><link/> https://www.news-medical.net/news/20231228/Insilico-Medicine-develops-new-AI- generated-FGFR23-inhibitor-for-tissue-agnostic-solid-tumors.aspx<comments> https://www.news-medical.net/news/20231228/Insilico-Medicine-develops-new-AI- generated-FGFR23-inhibitor-for-tissue-agnostic-solid-tumors.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=5a2d7e70-518f-4ee4-932c-bc6e6864bc58</guid><pubDate> Thu, 28 Dec 2023 20:33:43 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/abstract_image_Light_traces._visualization_of_hacker_attacks_on_information_data_-_Timofeev_Vladimir_M2_56ffa9d3b5124b35bda8ecb68b2931e0-620x480.jpg" width="620"><media:description><![CDATA[Insilico Medicine develops new AI-generated FGFR2/3 inhibitor for tissue-agnostic solid tumors]]></media:description></media:content></item><item><title> Lisocabtagene maraleucel：复发/难治性 DLBCL 的经济有效的二线治疗</title><description>根据今天发表的一项研究，Lisocabtagene maraleucel (liso-cel) 是一种 CAR T 细胞疗法，是一种具有成本效益的二线治疗复发性难治性（难以治疗）弥漫性大 B 细胞淋巴瘤 (r/r DLBCL)在血液进展中。</description><link/> https://www.news-medical.net/news/20231228/Lisocabtagene-maraleucel-A-cost-efficient-second-line-treatment-for-relapsedrefractory-DLBCL.aspx<comments> https://www.news-medical.net/news/20231228/Lisocabtagene-maraleucel-A-cost-efficient-second-line-treatment-for-relapsedrefractory-DLBCL.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=367e17db-6ae6-4a82-a31d-185541bdd4ad</guid><pubDate> Thu, 28 Dec 2023 20:07:01 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Chemo_Vials-620x480.jpg" width="620"><media:description><![CDATA[Lisocabtagene maraleucel: A cost-effective second-line treatment for relapsed/refractory DLBCL]]></media:description></media:content></item><item><title>研究发现，综合护理可能不是心理健康治疗的灵丹妙药</title><description>美国的医疗保健系统已逐渐接受这样的概念，即心理健康应与身体健康同等对待，特别是考虑到在 COVID-19 大流行期间和之后焦虑和抑郁的发生率增加。</description><link/> https://www.news-medical.net/news/20231228/Integrated-care-may-not-be-the-silver-bullet-for-mental-health-treatment-study-finds.aspx<comments> https://www.news-medical.net/news/20231228/Integrated-care-may-not-be-the-silver-bullet-for-mental-health-treatment-study-finds.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=6179aee6-0404-4fe1-9f64-e18f51dcb662</guid><pubDate> Thu, 28 Dec 2023 20:01:20 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/Abstract_medicine_background-Hilch-1000_f0a8c263e6e04ed18dfcc5ef27c17907-620x480.jpg" width="620"><media:description><![CDATA[Integrated care may not be the silver bullet for mental health treatment, study finds]]></media:description></media:content></item></channel></rss>